202 related articles for article (PubMed ID: 7657446)
1. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.
Shalita AR; Smith JG; Parish LC; Sofman MS; Chalker DK
Int J Dermatol; 1995 Jun; 34(6):434-7. PubMed ID: 7657446
[TBL] [Abstract][Full Text] [Related]
2. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
Khodaeiani E; Fouladi RF; Amirnia M; Saeidi M; Karimi ER
Int J Dermatol; 2013 Aug; 52(8):999-1004. PubMed ID: 23786503
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
4. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
[TBL] [Abstract][Full Text] [Related]
5. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
[TBL] [Abstract][Full Text] [Related]
6. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
[TBL] [Abstract][Full Text] [Related]
7. Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial.
Morganti P; Berardesca E; Guarneri B; Guarneri F; Fabrizi G; Palombo P; Palombo M
Int J Cosmet Sci; 2011 Oct; 33(5):467-76. PubMed ID: 21668835
[TBL] [Abstract][Full Text] [Related]
8. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
Leyden JJ; Berger RS; Dunlap FE; Ellis CN; Connolly MA; Levy SF
Am J Clin Dermatol; 2001; 2(1):33-9. PubMed ID: 11702619
[TBL] [Abstract][Full Text] [Related]
11. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
14. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
17. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne.
Cunliffe WJ; Fernandez C; Bojar R; Kanis R; West F;
J Dermatolog Treat; 2005; 16(4):213-8. PubMed ID: 16302325
[TBL] [Abstract][Full Text] [Related]
18. [Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies].
Gollnick HP; Graupe K; Zaumseil RP
J Dtsch Dermatol Ges; 2004 Oct; 2(10):841-7. PubMed ID: 16281587
[TBL] [Abstract][Full Text] [Related]
19. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
Kuhlman DS; Callen JP
Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]